BMC Endocrine Disorders Endocrinology, Diabetes and Metabolism

Alternate-day alternating monotherapy (q48h) versus daily concomitant atorvastatin–fenofibrate in adults with type 2 diabetes and mixed dyslipidemia: a 12-week randomized non-inferiority trial

Soheil Shahramirad, Milad Rezvani, Roya Jahanbazi, Mohammadreza Vataniman, Nasrin Razavianzadeh
Springer Nature · 2026-01-06 · DOI 10.1186/s12902-025-02156-z

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →